The strain, which is the newest addition to the company’s human health probiotics portfolio, achieved a “clinically meaningful response” for improving gut health for people with adults with IBS-D.
Chr. Hansen has received regulatory approval to supply a range of Human Milk Oligosaccharides (HMO) to new and existing global markets, following recent endorsements from Australia and New Zealand last year.
Chr. Hansen said it is launching The Probiotics Institute – a new platform providing educational and scientific content on probiotics and the human microbiome – due to the number of hits online for probiotics, which it said is around 55m.